HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis.
about
Statins and the risk of lung cancer: a meta-analysisMutant p53 disrupts mammary tissue architecture via the mevalonate pathwayMevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible LinkStatin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trialsChemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancerDrosophila Lung Cancer Models Identify Trametinib plus Statin as Candidate TherapeuticIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesThe potential effect of statins on rituximab immunotherapy.Dynamical modeling of the cholesterol regulatory pathway with Boolean networks.Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statinsLovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevanceStatin use and cancer risk: a comprehensive reviewStatins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes.mTORC2 is required for proliferation and survival of TSC2-null cells.Statin use and risk of breast cancer: a meta-analysis of observational studies.Statin use and risk of bladder cancer: a meta-analysis.Statins are associated with reduced risk of gastric cancer: a meta-analysis.Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies.27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.Synergic effect of eicosapentaenoic acid and lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cellsAnti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapyStatins and prostate cancer risk: a case-control study.A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemiaStatin use and female reproductive organ cancer risk in a large population-based setting.Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductaseSelective role of mevalonate pathway in regulating perforin but not FasL and TNFalpha release in human Natural Killer cellsStatin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma.Statin use and risk of lung cancer: a meta-analysis of observational studies and randomized controlled trials.Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database.Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents.Cancer therapy: new targets for chemotherapy.The coagulation system as a target for experimental therapy of human gliomas.Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink.Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia.Statin use and the risk of renal cell carcinoma in 2 prospective US cohortsModified fatty acids and their possible therapeutic targets in malignant diseases.Quantitative proteomic analysis revealed lovastatin-induced perturbation of cellular pathways in HL-60 cells.Statin use and the risk of colorectal cancer: a population-based case-control studyTumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.
P2860
Q21559688-C53511DD-3629-4F16-BC4D-E06AB7696460Q24302433-747BC3EB-CF1E-4D4F-84EE-4BB85964D740Q26799973-8CC4372A-D3F4-48B8-B9FA-6DF34B75B746Q26864662-DE8886FD-C97A-4C86-AF08-11611DD20453Q27026428-24580B3B-6E06-4738-80DF-CA780E75675EQ27319935-5A14EC44-1594-4A12-B6DD-18AE4D0F58C0Q28388335-4DAB5E96-39BB-4CC7-A5FB-04C6A9BE16B0Q33325581-22A4C42B-0979-42F0-AD6A-615965C7FE40Q33386247-A64DDF73-9B72-4D51-9783-14C4FC909651Q33507292-8D46F55B-892E-400C-9187-B5E2C56C25FAQ33542856-85955161-A48E-43EA-9F2C-522CAB1AED37Q34021312-5FA4C3F6-10C9-4B64-99A2-1051203377F8Q34087076-6F510712-BE71-4EE2-BFBB-CC8638939D06Q34177457-484B0665-92F9-4191-8167-E187D8BB4115Q34288756-E1FE7BA6-1823-42D3-8FEC-29D131960552Q34325144-BF221080-77AE-433D-BDF0-F6E9E8DC3402Q34349560-1BAD4962-9462-4E1D-B0BB-8837D402397AQ34387037-D31F41EB-3913-465F-9B10-7881DD2E2DB9Q34388715-DFD55918-1BEF-4175-B51E-417AF914A5F8Q34404997-11919BBD-E4F6-4634-9C84-4067C97697E8Q34429244-2AA886C3-0551-4CD5-BC9B-E7F2F6F396B2Q34433638-E147C14E-9A49-4F9B-822C-8DF68CC3EBC0Q34448969-3DD0375B-C90D-407D-8E1E-6B0EA1D2FE2CQ34585472-903C8A99-BA9C-4140-9DAA-379CDF8F6157Q34618889-7FF5D641-7649-494B-8A7B-6777378AA01EQ34687185-08C82578-BB02-40AF-947E-275624D8112CQ34717893-673666F1-BF9D-4EA0-ACDF-4664CD085B0CQ34757109-A8BFCB3B-917A-4AC4-82BA-C909C12FF6F2Q35035835-FC683C1F-5B53-41D9-8191-1E38677CC861Q35069176-1661B58B-E349-4ABD-9A86-742A91F3A862Q35088190-D174FD11-801E-4002-9309-813B87D3E567Q35126987-FA365FC9-DFD7-4E79-A5DA-D7E5CEA35D89Q35143910-DB2E8A2E-1949-4891-B504-A06CA04CC63CQ35152907-12A3D42D-67AF-4B32-A3B0-B68B71D0223DQ35186888-F1037184-89BF-48B2-90B2-59745A5FFB2DQ35354232-05DF47C6-67DA-4D3B-9720-A913A434B277Q35537914-02F155C7-2995-4E8C-A803-4ED4985423B9Q35592559-774407EC-FA75-4597-B6BD-A517A9BD641CQ35627285-6F938B58-A037-45D0-B40D-193D812733D2Q35673791-D72C6E07-A02F-4C13-8615-A8785919D474
P2860
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
HMG-CoA reductase inhibitors a ...... s of tumor-specific apoptosis.
@ast
HMG-CoA reductase inhibitors a ...... s of tumor-specific apoptosis.
@en
HMG-CoA reductase inhibitors a ...... s of tumor-specific apoptosis.
@nl
type
label
HMG-CoA reductase inhibitors a ...... s of tumor-specific apoptosis.
@ast
HMG-CoA reductase inhibitors a ...... s of tumor-specific apoptosis.
@en
HMG-CoA reductase inhibitors a ...... s of tumor-specific apoptosis.
@nl
prefLabel
HMG-CoA reductase inhibitors a ...... s of tumor-specific apoptosis.
@ast
HMG-CoA reductase inhibitors a ...... s of tumor-specific apoptosis.
@en
HMG-CoA reductase inhibitors a ...... s of tumor-specific apoptosis.
@nl
P2093
P356
P1433
P1476
HMG-CoA reductase inhibitors a ...... s of tumor-specific apoptosis.
@en
P2093
P2888
P304
P356
10.1038/SJ.LEU.2402476
P577
2002-04-01T00:00:00Z
P5875
P6179
1045091558